@valueadd 100% agree ,,, looked to me like a Funder was lined up ,, possibly CHM stated results are just around the corner and would act as an inflection point ,, so the Funder then stretched it out ,, results didn't crystalize as soon as CHM may have indicated and then the Funder walked..
Unbelievable to have a Complete Response Announcement whilst in suspension , then the CR takes place........... ????? @ .008c.. then it would seem Hopper had to stump up 20% to show confidence and have addition hurt money on CHM. But .008c?? ouch
Happy to hold as you and I know ,, The Science is Great ,,, Company Messaging leaves a lot to be desired but now Hopper and Co are Balls deep in stock at least we know they will invest more energy and focus on CHM..
I'm amazed we haven't had a low ball take over offer ,,, consolidation wont be far away... SOI for an $8m MC Company is off the scale.
MC $8m for CHM,,, there is no other ASX Biotech that has completed a Phase I Human Trial under $100m so plenty of upside here NZT
(20min delay)